Capecitabine in combination with Docetaxel in first line in HER2-Negative metastatic breast cancer: an observational study

Kószó Renáta Lilla, Sántha Dóra, Büdi László, Erfán József, Győrfy Károly, Horváth Zsolt, Kocsis Judit, Landherr László, Hitre Erika, Máhr Károly, Pajkos Gábor, Pápai Zsuzsanna, Kahán Zsuzsanna: Capecitabine in combination with Docetaxel in first line in HER2-Negative metastatic breast cancer: an observational study.
PATHOLOGY AND ONCOLOGY RESEARCH, 23 (3). pp. 505-511. ISSN 1219-4956 (2017)

[img]
Preview
Text
s12253_016_0129_7_u.pdf - Published Version

Download (362kB) | Preview
Item Type: Article
Journal or Publication Title: PATHOLOGY AND ONCOLOGY RESEARCH
Date: 2017
Volume: 23
Number: 3
Page Range: pp. 505-511
ISSN: 1219-4956
Publisher: Springer Netherlands
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
SWORD language: Angol
Identification Number: 3151638
DOI id: https://doi.org/10.1007/s12253-016-0129-7
Related URLs:
Date Deposited: 2018. Jan. 08. 10:17
Last Modified: 2018. Jan. 08. 10:17
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12504

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year